<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Pharmaceutical and Biomedical Research</title>
<title_fa></title_fa>
<short_title>Pharm Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://pbr.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-4486</journal_id_issn>
<journal_id_issn_online>2423-4494</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/pbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>8</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effects of Hydroalcoholic Extract of Lepidium Sativum L. on Carbon Tetrachloride-Induced Hepatotoxicity in Mice</title>
	<subject_fa>فارماکوگنوزی</subject_fa>
	<subject>Pharmacognosy</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Background:&lt;/strong&gt; Carbon tetrachloride (CCl4) as an organic solvent causes symptoms of acute and chronic liver injury, including necrosis, fat changes, liver cancer, and cirrhosis.&amp;nbsp;Lepidium sativum contains flavonoids, alkaloids, and antioxidant components.&lt;br&gt;
Objectives: This study aims to investigate the hepatic protection of&amp;nbsp;L. Sativum Extract (LSE) on CCl4-induced hepatotoxicity in mice.&lt;br&gt;
&lt;strong&gt;Methods: &lt;/strong&gt;A total of 25 male mice were randomly divided into five groups (n=5): control (olive oil), CCl4, and 3 LSE groups. Except for the control group, all the mice received CCl4 (50%, 0.5 mL/kg) intraperitoneally twice a week for 4 weeks. The mice in the LSE groups were treated daily with LSE (200, 400, and 600 mg/kg) via IP injection. The animals were sacrificed 24 h after the last dose, and liver function parameters, such as Alkaline Phosphatase (ALP), Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), and Glutathione (GSH) were determined. Furthermore, 0.1 g of liver tissue was removed for histochemical analysis.&lt;br&gt;
&lt;strong&gt;Results:&lt;/strong&gt; Significant differences were observed in GSH, ALP, AST, and ALT levels between the CCI4 and the control groups. Compared to the CCl4 group, LSE treatment significantly decreased plasma ALT (P&lt;0.05), AST in all doses (P&lt;0.001), and ALP in 600 mg/kg (P&lt;0.001). In addition, LSE treatment significantly increased GSH in 400 mg/kg (P&lt;0.01) and 600 mg/kg (P&lt;0.001).&lt;br&gt;
&lt;strong&gt;Conclusion:&lt;/strong&gt; LSE has hepatic protective activity against CCl4-induced injuries. The possible anti-hepatotoxic mechanisms may be related to&amp;nbsp;the presence of flavonoids, triterpenes, alkaloids, tannin, and coumarins in the LSE by inhibiting the free radicals mediated damage.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Alanine transaminase, Alkaline phosphatase, Aspartate aminotransferases, Glutathione, Toxic hepatitis</keyword>
	<start_page>225</start_page>
	<end_page>232</end_page>
	<web_url>http://pbr.mazums.ac.ir/browse.php?a_code=A-10-780-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mohammad</first_name>
	<middle_name></middle_name>
	<last_name>Shokrzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mslamuk@yahoo.com</email>
	<code>100319475328460010212</code>
	<orcid>100319475328460010212</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Toxicology and Pharmacology, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Reza</first_name>
	<middle_name></middle_name>
	<last_name>Khalvati</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460010213</code>
	<orcid>100319475328460010213</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Food and Drug Administration, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad Hossein</first_name>
	<middle_name></middle_name>
	<last_name>Hosseinzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>iranmhhz@gmail.com</email>
	<code>100319475328460010214</code>
	<orcid>100319475328460010214</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medicinal Plants Research Center, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mona</first_name>
	<middle_name></middle_name>
	<last_name>Ayatifard</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>emrapharm@gmail.com</email>
	<code>100319475328460010215</code>
	<orcid>100319475328460010215</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Student Research Committee, School of Pharmacy, Ramsar International Campus, Mazandaran University of Medical Sciences, Ramsar, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Emran</first_name>
	<middle_name></middle_name>
	<last_name>Habibi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>emrapharm@yahoo.com</email>
	<code>100319475328460010216</code>
	<orcid>100319475328460010216</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Pharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
